Appeal No. 2003-1126 Page 5 Application No. 08/444,285 reasonably provide enablement for the breadth of the claims to transgenic rodents, rabbits, goats, pigs, cattle or sheep expressing any genetic material of interest under obtainable conditions, and methods of producing a polypeptide of interest in the above listed transgenic mammals. . . . The specification does not enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the invention commensurate in scope with these claims. Examiner’s Answer, pages 3-4. The rejection addresses the relevant Wands factors. See In re Wands, 858 F.2d 731, 737, 8 USPQ2d 1400, 1403 (Fed. Cir. 1988). Factors that should be considered in determining whether a specification is enabling, or if it would require an undue amount of experimentation to practice the invention include: (1) the quantity of experimentation necessary to practice the invention, (2) the amount of direction or guidance presented, (3) the presence or absence of working examples, (4) the nature of the invention, (5) the state of the prior art, (6) the relative skill of those in the art, (7) the predictability or unpredictability of the art, and (8) the breadth of the claims. See id. With respect to the nature of the invention, the examiner comments that the claimed invention is drawn to a transgenic nonhuman mammal whose genome contains at least one heterologous gene and a transcriptional control sequence operatively associated where the mammal expresses the gene at a detectable level in a plurality of the mammal’s cells, and the methods of producing a polypeptide or protein in the transgenic mammal or progeny of the transgenic mammal. The mammal can be anyone of a rodent, rabbit, goat, pig, cattle and sheep. The protein can be any polypeptide or protein. Examiner’s Answer, page 4. According to the rejection, “[a] compelling feature of a transgenic mammal is that the heterologous genetic material is present in all, orPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 NextLast modified: November 3, 2007